← SynDRA
ibrutinib
SynDRA canonical compound SYN0042985 — structure-anchored drug synonym record
| Primary target(s) | BTK |
|---|
| Mechanism of action | BTK inhibitor |
|---|
All known targets
- BTK
- BLK
- BMX
- EGFR
- ERBB2
- ERBB4
- FYN
- HCK
- ITK
- JAK3
- LCK
- LYN
Mechanisms of action (all sources)
- BTK INHIBITOR
- BLK INHIBITOR
- BMX INHIBITOR
- EGFR INHIBITOR
- ERBB2 INHIBITOR
- ERBB4 INHIBITOR
- FYN INHIBITOR
- HCK INHIBITOR
- ITK INHIBITOR
- JAK3 INHIBITOR
- LCK INHIBITOR
- LYN INHIBITOR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- PCI-32765 (Racemate)
- Ibrutinib Racemate
- PCI-32765 Racemate
- Ibrutinib (Racemate)
- IBRUTINIB IMPURITY 88
- C25H24N6O2
- PCI-32765 (Ibrutinib)
- US8497277, 13
- SCHEMBL201642
- BDBM1773
- SCHEMBL16494959
- CHEBI:91397
- XYFPWWZEPKGCCK-UHFFFAOYSA-N
- HMS3295G01
- HMS3656P11
- HMS3749K05
- HMS3750C19
- HMS5081P13
- DMC97717
- LMB56387
- EBC-44150
- HY-10997A
- MFCD12032093
- NSC761910
- s2680
- AKOS026750227
- CCG-264978
- EX-5965
- NSC-761910
- SB14736
- SDCCGSBI-0647574.P002
- NCGC00387861-02
- NCGC00387861-03
- AS-16305
- DB-049805
- DB-079642
- G87616
- US8476284, 4
- US8497277, 4
Look up ibrutinib in the interactive SynDRA portal →